logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi

Libamba E, Makombe SD, Mhango E, de Ascurra Teck O, Limbambala E, Schouten EJ, Harries AD
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
OBJECTIVE
To describe the supervision, monitoring and evaluation strategies used to assess the delivery of antiretroviral therapy during nationwide scale-up of treatment in Malawi.

METHODS
In the first quarter of 2005, the HIV Unit of the Ministry of Health and its partners (the Lighthouse Clinic; Médecins Sans Frontières-Belgium, Thyolo district; and WHO's Country Office) undertook structured supervision and monitoring of all public sector health facilities in Malawi delivering antiretroviral therapy.

FINDINGS
Data monitoring showed that by the end of 2004, there were 13,183 patients (5274 (40%) male, 12 527 (95%) adults) who had ever started antiretroviral therapy. Of patients who had ever started, 82% (10 761/13,183) were alive and taking antiretrovirals; 8% (1026/13,183) were dead; 8% (1039/13,183) had been lost to follow up; <1% (106/13,183) had stopped treatment; and 2% (251/13,183) had transferred to another facility. Of those alive and on antiretrovirals, 98% (7098/7258) were ambulatory; 85% (6174/7258) were fit to work; 10% (456/4687) had significant side effects; and, based on pill counts, 96% (6824/7114) had taken their treatment correctly. Mistakes in the registration and monitoring of patients were identified and corrected. Drug stocks were checked, and one potential drug stock-out was averted. As a result of the supervisory visits, by the end of March 2005 recruitment of patients to facilities scheduled to start delivering antiretroviral therapy had increased.

CONCLUSION
This report demonstrates the importance of early supervision for sites that are starting to deliver antiretroviral therapy, and it shows the value of combining data collection with supervision. Making regular supervisory and monitoring visits to delivery sites are essential for tracking the national scale-up of delivery of antiretrovirals.

Countries

Belgium Malawi

Languages

English
DOI
/S0042-96862006000400017
Published Date
13 Apr 2006
PubMed ID
16628306
Journal
Bulletin of the World Health Organization
Volume | Issue | Pages
Volume 84, Issue 4, Pages 320-326
Dimensions Badge